Bioventix PLC (LON:BVXP – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 2,780.04 ($37.33) and traded as high as GBX 2,800 ($37.60). Bioventix shares last traded at GBX 2,795 ($37.53), with a volume of 3,678 shares.
Bioventix Trading Up 5.0%
The company has a market capitalization of £149.76 million, a price-to-earnings ratio of 18.50 and a beta of 0.35. The stock has a 50-day simple moving average of GBX 2,780.04 and a 200-day simple moving average of GBX 2,817.93.
Insider Buying and Selling at Bioventix
In other news, insider Bruce Hiscock acquired 31 shares of Bioventix stock in a transaction dated Monday, April 28th. The stock was bought at an average cost of GBX 2,632 ($35.34) per share, with a total value of £815.92 ($1,095.64). Insiders own 8.02% of the company’s stock.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Further Reading
- Five stocks we like better than Bioventix
- Golden Cross Stocks: Pattern, Examples and Charts
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- Investing in Construction Stocks
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- 3 Warren Buffett Stocks to Buy Now
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.